Century Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $109,164 |
Gross Profit | -3,550 | -3,129 | -3,201 | 109,164 |
EBITDA | -18,703 | -31,293 | -29,340 | 77,397 |
EBIT | -22,253 | -34,422 | -32,541 | 74,176 |
Net Income | -19,177 | -34,422 | -32,540 | 76,560 |
Net Change In Cash | 0 | 0 | 0 | 109,164 |
Free Cash Flow | -16,394 | -25,779 | -27,909 | -34,623 |
Cash | 61,853 | 55,515 | 56,878 | 51,865 |
Basic Shares | 86,556 | 86,464 | 86,238 | 86,098 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $109,164 | $6,589 | $2,235 | $5,199 |
Gross Profit | 96,063 | 6,589 | 2,235 | 5,199 |
EBITDA | -1,939 | -111,472 | -121,208 | -121,201 |
EBIT | -15,040 | -124,776 | -134,252 | -129,641 |
Net Income | -9,580 | -126,566 | -136,673 | -130,932 |
Net Change In Cash | 109,164 | 6,589 | 2,235 | 5,199 |
Cost of Revenue | 28,082 | |||
Free Cash Flow | -104,724 | -110,289 | -102,084 | -16,552 |
Cash | 61,853 | 58,441 | 47,324 | 84,265 |
Basic Shares | 86,556 | 78,648 | 59,314 | 57,755 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.25 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.38 |
